D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
KRSA holding history
Korsana Biosciences, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KRSA overviewAll 13F holders of KRSAFull Q2 2026 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −122,249−100.0% | Sold out | Holders |
| Q1 2022 | 122,249 | $136.0K | <0.1% | −14,360−10.5% | Reduced | Holders |
| Q4 2021 | 136,609 | $235.0K | <0.1% | −135,945−49.9% | Reduced | Holders |
| Q3 2021 | 272,554 | $837.0K | <0.1% | −102,706−27.4% | Reduced | Holders |
| Q2 2021 | 375,260 | $1.46M | <0.1% | +306,788+448.0% | Added | Holders |
| Q1 2021 | 68,472 | $191.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.